Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research explores GHK-Cu peptide microspheres for bone repair. Learn what the study found about osteogenic and angiogenic activity in this evidence-based review.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may help restore anti-tumor immunity after chemotherapy by activating dendritic cells. Learn what the study found.
By Peptide Association Research Team
New research links mitochondrial dysfunction and oxidative stress to gestational diabetes, placental problems, and offspring metabolic risk. Learn what the science shows.
By Peptide Association Research Team
New research explores oleogel systems that may improve resveratrol bioavailability. Learn what the 2026 Food Chemistry study found and what it means for supplementation.
By Peptide Association Research Team
New research identifies cathepsin B as a key driver of gut barrier breakdown in alcohol-associated liver disease. Learn what the study found and why it matters.
By Peptide Association Research Team
New research suggests SS-31 (Elamipretide) may modulate alpha-synuclein aggregation and restore mitochondrial function in Parkinson's-related models.
By Peptide Association Research Team
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy. Learn what the study found.
By Peptide Association Research Team
New research suggests the peptide SS-31 (Elamipretide) may modulate α-synuclein aggregation and restore mitochondrial function linked to Parkinson's disease.
By Peptide Association Research Team
New research explores repurposed drugs targeting Alzheimer's disease pathways. Learn what the latest evidence suggests about emerging therapeutic strategies.
By Peptide Association Research Team
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy by reducing oxidative stress.
By Peptide Association Research Team
A 2026 ACS Nano study suggests mitochondria-targeted nanoparticles may reduce liver ischemia-reperfusion injury by limiting ROS and inflammation in mice.
By Peptide Association Research Team
New research explores how mitochondria-targeted polydopamine nanoparticles modified with SS-31 peptide may protect the liver from ischemia-reperfusion injury.
By Peptide Association Research Team
New research reframes how the MASCC Risk Index predicts febrile neutropenia complications using likelihood ratios and Bayesian probability for better bedside decisions.
By Peptide Association Research Team
A 2026 review study examines nanocarriers, host-directed therapies, and antimicrobial peptides as next-generation tuberculosis treatment strategies.
By Peptide Association Research Team
A 2026 review study explores nanocarriers, host-directed therapies, and antimicrobial peptides as next-generation tuberculosis treatments. Learn what the research shows.
By Peptide Association Research Team
New research explores nanocarriers, antimicrobial peptides, and host-directed strategies as next-generation tuberculosis treatments. Learn what the science says.
By Peptide Association Research Team
New zebrafish research suggests GHK-Cu peptide may reduce inflammation and oxidative stress. Learn what the study found and what it means for future research.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by protecting mitochondria and reducing cell death. Learn what the study found.
By Peptide Association Research Team
New research explores an engineered inhalable powder combining niclosamide and colistin to combat drug-resistant lung infections in cystic fibrosis patients.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives inflammation and beta-cell death in type 2 diabetes—and what emerging therapies may mean for patients.
By Peptide Association Research Team
New research explores carbonless analogues of the GHK peptide using boron-nitrogen substitution. Learn what this computational study suggests about future peptide design.
By Peptide Association Research Team
New computational research explores carbonless analogues of GHK peptide, suggesting stronger copper binding and broader conformational flexibility. Learn what this means.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 may protect against heart damage from chemotherapy drugs through H2O2 regulation mechanisms.
By Peptide Association Research Team
Groundbreaking 2026 study uncovers how mitochondrial dysfunction drives inflammation and cell death in type 2 diabetes, pointing to new treatment paths.
By Peptide Association Research Team